Cargando…

RANK-ligand and osteoprotegerin as biomarkers in the differentiation between periprosthetic joint infection and aseptic prosthesis loosening

AIM: To assess serum levels of RANK-ligand (RANKL) and osteoprotegerin (OPG) as biomarkers for periprosthetic joint infection (PJI) and compare their accuracy with standard tests. METHODS: One hundred and twenty patients presenting with a painful total knee or hip arthroplasty with indication for su...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedrich, Max J, Wimmer, Matthias D, Schmolders, Jan, Strauss, Andreas C, Ploeger, Milena M, Kohlhof, Hendrik, Wirtz, Dieter C, Gravius, Sascha, Randau, Thomas M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396020/
https://www.ncbi.nlm.nih.gov/pubmed/28473963
http://dx.doi.org/10.5312/wjo.v8.i4.342
_version_ 1783229988918525952
author Friedrich, Max J
Wimmer, Matthias D
Schmolders, Jan
Strauss, Andreas C
Ploeger, Milena M
Kohlhof, Hendrik
Wirtz, Dieter C
Gravius, Sascha
Randau, Thomas M
author_facet Friedrich, Max J
Wimmer, Matthias D
Schmolders, Jan
Strauss, Andreas C
Ploeger, Milena M
Kohlhof, Hendrik
Wirtz, Dieter C
Gravius, Sascha
Randau, Thomas M
author_sort Friedrich, Max J
collection PubMed
description AIM: To assess serum levels of RANK-ligand (RANKL) and osteoprotegerin (OPG) as biomarkers for periprosthetic joint infection (PJI) and compare their accuracy with standard tests. METHODS: One hundred and twenty patients presenting with a painful total knee or hip arthroplasty with indication for surgical revision were included in this prospective clinical trial. Based on standard diagnostics (joint aspirate, microbiological, and histological samples) and Musculoskeletal Infection Society consensus classification, patients were categorized into PJI, aseptic loosening, and control groups. Implant loosening was assessed radiographically and intraoperatively. Preoperative serum samples were collected and analyzed for RANKL, OPG, calcium, phosphate, alkaline phosphatase (AP), and the bone-specific subform of AP (bAP). Statistical analysis was carried out, testing for significant differences between the three groups and between stable and loose implants. RESULTS: All three groups were identical in regards to age, gender, and joint distribution. No statistically significant differences in the serum concentration of RANKL (P = 0.16) and OPG (P = 0.45) were found between aseptic loosening and PJI, with a trend towards lower RANKL concentrations and higher OPG concentrations in the PJI group. The RANKL/OPG ratio was significant for the comparison between PJI and non-PJI (P = 0.005). A ratio > 60 ruled out PJI in all cases (specificity: 100%, 95%CI: 89, 11% to 100.0%) but only 30% of non-PJI patients crossed this threshold. The positive predictive value remained poor at any cut-off. In the differentiation between stable and loose implants, none of the parameters measured (calcium, phosphate, AP, and bAP) showed a significant difference, and only AP and bAP measurements showed a tendency towards higher values in the loosened group (with P = 0.09 for AP and P = 0.19 for bAP). CONCLUSION: Lower RANKL and higher OPG concentrations could be detected in PJI, without statistical significance.
format Online
Article
Text
id pubmed-5396020
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-53960202017-05-04 RANK-ligand and osteoprotegerin as biomarkers in the differentiation between periprosthetic joint infection and aseptic prosthesis loosening Friedrich, Max J Wimmer, Matthias D Schmolders, Jan Strauss, Andreas C Ploeger, Milena M Kohlhof, Hendrik Wirtz, Dieter C Gravius, Sascha Randau, Thomas M World J Orthop Clinical Trials Study AIM: To assess serum levels of RANK-ligand (RANKL) and osteoprotegerin (OPG) as biomarkers for periprosthetic joint infection (PJI) and compare their accuracy with standard tests. METHODS: One hundred and twenty patients presenting with a painful total knee or hip arthroplasty with indication for surgical revision were included in this prospective clinical trial. Based on standard diagnostics (joint aspirate, microbiological, and histological samples) and Musculoskeletal Infection Society consensus classification, patients were categorized into PJI, aseptic loosening, and control groups. Implant loosening was assessed radiographically and intraoperatively. Preoperative serum samples were collected and analyzed for RANKL, OPG, calcium, phosphate, alkaline phosphatase (AP), and the bone-specific subform of AP (bAP). Statistical analysis was carried out, testing for significant differences between the three groups and between stable and loose implants. RESULTS: All three groups were identical in regards to age, gender, and joint distribution. No statistically significant differences in the serum concentration of RANKL (P = 0.16) and OPG (P = 0.45) were found between aseptic loosening and PJI, with a trend towards lower RANKL concentrations and higher OPG concentrations in the PJI group. The RANKL/OPG ratio was significant for the comparison between PJI and non-PJI (P = 0.005). A ratio > 60 ruled out PJI in all cases (specificity: 100%, 95%CI: 89, 11% to 100.0%) but only 30% of non-PJI patients crossed this threshold. The positive predictive value remained poor at any cut-off. In the differentiation between stable and loose implants, none of the parameters measured (calcium, phosphate, AP, and bAP) showed a significant difference, and only AP and bAP measurements showed a tendency towards higher values in the loosened group (with P = 0.09 for AP and P = 0.19 for bAP). CONCLUSION: Lower RANKL and higher OPG concentrations could be detected in PJI, without statistical significance. Baishideng Publishing Group Inc 2017-04-18 /pmc/articles/PMC5396020/ /pubmed/28473963 http://dx.doi.org/10.5312/wjo.v8.i4.342 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Clinical Trials Study
Friedrich, Max J
Wimmer, Matthias D
Schmolders, Jan
Strauss, Andreas C
Ploeger, Milena M
Kohlhof, Hendrik
Wirtz, Dieter C
Gravius, Sascha
Randau, Thomas M
RANK-ligand and osteoprotegerin as biomarkers in the differentiation between periprosthetic joint infection and aseptic prosthesis loosening
title RANK-ligand and osteoprotegerin as biomarkers in the differentiation between periprosthetic joint infection and aseptic prosthesis loosening
title_full RANK-ligand and osteoprotegerin as biomarkers in the differentiation between periprosthetic joint infection and aseptic prosthesis loosening
title_fullStr RANK-ligand and osteoprotegerin as biomarkers in the differentiation between periprosthetic joint infection and aseptic prosthesis loosening
title_full_unstemmed RANK-ligand and osteoprotegerin as biomarkers in the differentiation between periprosthetic joint infection and aseptic prosthesis loosening
title_short RANK-ligand and osteoprotegerin as biomarkers in the differentiation between periprosthetic joint infection and aseptic prosthesis loosening
title_sort rank-ligand and osteoprotegerin as biomarkers in the differentiation between periprosthetic joint infection and aseptic prosthesis loosening
topic Clinical Trials Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396020/
https://www.ncbi.nlm.nih.gov/pubmed/28473963
http://dx.doi.org/10.5312/wjo.v8.i4.342
work_keys_str_mv AT friedrichmaxj rankligandandosteoprotegerinasbiomarkersinthedifferentiationbetweenperiprostheticjointinfectionandasepticprosthesisloosening
AT wimmermatthiasd rankligandandosteoprotegerinasbiomarkersinthedifferentiationbetweenperiprostheticjointinfectionandasepticprosthesisloosening
AT schmoldersjan rankligandandosteoprotegerinasbiomarkersinthedifferentiationbetweenperiprostheticjointinfectionandasepticprosthesisloosening
AT straussandreasc rankligandandosteoprotegerinasbiomarkersinthedifferentiationbetweenperiprostheticjointinfectionandasepticprosthesisloosening
AT ploegermilenam rankligandandosteoprotegerinasbiomarkersinthedifferentiationbetweenperiprostheticjointinfectionandasepticprosthesisloosening
AT kohlhofhendrik rankligandandosteoprotegerinasbiomarkersinthedifferentiationbetweenperiprostheticjointinfectionandasepticprosthesisloosening
AT wirtzdieterc rankligandandosteoprotegerinasbiomarkersinthedifferentiationbetweenperiprostheticjointinfectionandasepticprosthesisloosening
AT graviussascha rankligandandosteoprotegerinasbiomarkersinthedifferentiationbetweenperiprostheticjointinfectionandasepticprosthesisloosening
AT randauthomasm rankligandandosteoprotegerinasbiomarkersinthedifferentiationbetweenperiprostheticjointinfectionandasepticprosthesisloosening